How to Test for Intestinal Parasites

Testing for intestinal parasites typically starts with a stool sample, but the specific laboratory method your doctor orders makes a huge difference in whether the parasite is actually found. The traditional ova and parasite (O&P) microscopy exam, in which a technician examines preserved stool under a microscope, remains widely used but is surprisingly insensitive for many common infections. Newer molecular and antigen-based tests catch parasites that microscopy routinely misses, and knowing which test suits which situation can spare you weeks of repeat visits and lingering symptoms.

The Standard Stool Ova and Parasite Exam

When most people hear “parasite test,” they picture the O&P exam. A lab technician processes your stool sample through concentration steps that separate parasite eggs, cysts, and larvae from the rest of the fecal material, then examines the concentrate under a microscope. The exam can also include permanently stained smears, where dyes help reveal internal structures of protozoan organisms that would otherwise be invisible. Concentration is important because parasites are often sparse in stool; studies comparing multiple systems have found that all concentration methods outperform direct examination of unconcentrated material, with differences mainly in sediment clarity and the amount of debris left behind.

1PubMed Central. Parasite detection efficiencies of five stool concentration systems

Despite being the oldest and most familiar test, O&P microscopy has well-documented blind spots. It is considered relatively insensitive overall, and symptoms often do not line up with the window when eggs or cysts actually appear in the stool.

2PubMed Central. Eosinophilia in Infectious Diseases

Many parasites that cause tissue-level problems, particularly helminths migrating through organs, never shed detectable stages in stool at all. For the parasites that do shed into stool, microscopy depends heavily on the skill of the person reading the slide. A large modeling study on Giardia found that a senior microscopist’s sensitivity on a single slide was roughly 64%, while a junior microscopist’s was about 46%.

3PubMed Central. Disentangling the effects of intermittent faecal shedding and imperfect test sensitivity on the microscopy-based detection of gut parasites in stool samples

Hospital guidelines have tried to reduce unnecessary O&P orders. An audit across a multi-hospital system concluded that stool O&P exams should be limited to patients admitted for fewer than three days who have had diarrhea lasting more than a week and at least one risk factor such as travel to an endemic area, HIV-positive status, a history of parasitic disease, or institutionalization.

4PubMed Central. An audit of inpatient stool ova and parasite (O&P) testing in a multi-hospital health system

The reasoning is straightforward: if you have been in a hospital for several days and develop diarrhea, a parasite is far less likely than a hospital-acquired bacterial infection, and the O&P exam’s low sensitivity makes it a poor screening tool when the pre-test probability is already low.

Why One Sample Often Is Not Enough

Parasites do not shed eggs or cysts on a neat schedule. Many species release them in waves, so a stool sample collected on a “quiet” day can come back negative even when the infection is active. This intermittent shedding is separate from the limitations of whatever laboratory test is used. Even with a hypothetically perfect test that never missed a parasite stage when it was present, the chance of detecting Giardia from a single stool sample of an infected person was estimated at only about 44%, simply because Giardia cysts are not always present in the feces on any given day.

3PubMed Central. Disentangling the effects of intermittent faecal shedding and imperfect test sensitivity on the microscopy-based detection of gut parasites in stool samples

Collecting and pooling three separate stool samples, ideally on different days, pushes that theoretical detection probability up to roughly 82%. This is why doctors often request three specimens rather than just one. It is also why a single negative result does not rule out infection if your symptoms and risk factors still point toward a parasite.

How Stool Samples Are Preserved

What happens to the sample between collection and examination matters more than most patients realize. Protozoan trophozoites, the active feeding forms of organisms like amoebae, begin to degrade within minutes of leaving the body. If a fresh sample cannot reach the lab quickly, it needs to be placed into a chemical preservative.

For decades, the gold-standard fixative was polyvinyl alcohol (PVA) containing mercuric chloride, which excelled at preserving parasite morphology for permanently stained smears. The problem is that mercuric chloride is toxic and creates hazardous waste disposal headaches.

5PubMed Central. Comparison of polyvinyl alcohol fixative with three less hazardous fixatives for detection and identification of intestinal parasites

Laboratories have been migrating toward mercury-free alternatives. Evaluations of commercial single-vial preservatives have found acceptable substitutes for both formalin and PVA, with products like Ecofix performing comparably to the traditional system for visualizing protozoa in stained smears.

6PubMed Central. Evaluation of commercially available preservatives for laboratory detection of helminths and protozoa in human fecal specimens

Non-formalin fixatives also show promise; one evaluation found that a tissue fixative called STF preserved parasite morphology comparably to formalin for concentration exams and special stains, though it required modifications to the trichrome staining procedure to reach the same quality as PVA for protozoan cysts.

7PubMed. Evaluation of Streck tissue fixative, a nonformalin fixative for preservation of stool samples and subsequent parasitologic examination

For you as a patient, the practical takeaway is simple: follow whatever collection instructions you receive. If the kit contains a vial of liquid, that is the preservative, and the sample needs to go into it immediately. If there is no preservative and you are told to deliver a fresh specimen, get it to the lab within the time window you are given, usually under an hour for protozoan trophozoites.

Rapid Antigen Tests

For the two most commonly sought parasites in developed countries, Giardia and Cryptosporidium, antigen-based tests offer a faster and more reliable alternative to microscopy. These tests detect specific proteins shed by the parasite rather than relying on a technician to visually spot a cyst or oocyst. Some are lateral-flow immunochromatographic assays, essentially the same strip-test format used in home pregnancy tests, and can produce results in under 15 minutes.

Performance numbers for these rapid tests are consistently strong. One evaluation of a Giardia-specific rapid assay found sensitivity of about 97% and specificity of 100%.

8PubMed Central. Detection of Giardia lamblia antigens in human fecal specimens by a solid-phase qualitative immunochromatographic assay

A separate study testing point-of-care kits for both Giardia and Cryptosporidium reported sensitivity and specificity of 94% and 100% for Giardia and 100% and 100% for Cryptosporidium.

9PubMed Central. Evaluation of rapid antigen point-of-care tests for detection of Giardia and Cryptosporidium species in human fecal specimens

Fluorescent antibody microscopy, another antigen-based approach, also demonstrates high sensitivity for both organisms.

10PubMed Central. Diagnostic accuracy of ARK Checker® C/G-DyLight® 488: simultaneous detection of Giardia and Cryptosporidium by fluorescent antibody microscopy

The limitation of antigen tests is their narrow scope. They detect only the organism they were designed for. If you have a hookworm infection or Strongyloides, a Giardia antigen kit will tell you nothing. They are best used when clinical suspicion points toward a specific pathogen, not as a general screening tool for “any parasite.”

Molecular Testing With PCR

PCR-based tests, which amplify tiny fragments of parasite DNA, have changed the diagnostic landscape for intestinal protozoa. Where microscopy depends on finding an intact, recognizable parasite stage and the skill of the reader, PCR can detect genetic material from degraded or sparse organisms that a microscope would miss entirely.

The performance gap is striking. A prospective study analyzing 3,500 stool samples over three years found that multiplex PCR detected Giardia in about 1.3% of samples, while microscopy caught it in only 0.7%. For Dientamoeba fragilis, the gap was enormous: PCR flagged nearly 9% of samples, versus well under 1% by microscopy. For Blastocystis, PCR positivity was about 19%, compared to roughly 7% by microscopy.

11PubMed Central. Improvement of the diagnosis of intestinal protozoa using a multiplex qPCR strategy compared to classical microscopy: a prospective study on 3,500 stool samples over 3 years

Another evaluation found PCR sensitivity for Giardia was 100% compared to about 61% for microscopy, and for Blastocystis roughly 99% versus 44%.

12PubMed Central. Evaluation of the Allplexâ„¢ Gastrointestinal Panel-Parasite Assay for Protozoa Detection in Stool Samples: A Retrospective and Prospective Study

Multiplex PCR panels can screen for several parasites simultaneously from a single stool sample, offering sensitivity and specificity that match or exceed running separate single-target PCR tests for each organism.

13PubMed. Multiplex PCR for gastrointestinal parasites in stool: Benchmarking against direct microscopy and simplex PCR

These panels are increasingly available in hospital and reference laboratories, and some gastrointestinal pathogen panels used in emergency departments already include parasite targets alongside bacteria and viruses.

PCR does have caveats. It is generally more expensive than microscopy or antigen testing. It excels at protozoa but may not be the first choice when helminth infection is the concern. The same three-year prospective study noted that microscopy should still be performed when infections with certain helminths or with Cystoisospora belli (common in immunocompromised patients) are suspected.

11PubMed Central. Improvement of the diagnosis of intestinal protozoa using a multiplex qPCR strategy compared to classical microscopy: a prospective study on 3,500 stool samples over 3 years

When Species Identification Matters

Sometimes it is not enough to know that a parasite is present. You need to know exactly which species it is, and microscopy alone cannot always deliver that answer. The best-known example involves Entamoeba. Under a microscope, the dangerous Entamoeba histolytica, which can invade the liver and cause abscesses, looks identical to the harmless Entamoeba dispar, which lives in the gut without causing disease. A third lookalike, Entamoeba moshkovskii, further complicates identification. Microscopy cannot distinguish among them.

14PubMed Central. Comparison of PCR, isoenzyme analysis, and antigen detection for diagnosis of Entamoeba histolytica infection

PCR can separate these species reliably. Studies using PCR assays targeting specific gene sequences have successfully differentiated E. histolytica, E. dispar, and E. moshkovskii from stool samples.

15PubMed Central. PCR detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in stool samples from Sydney, Australia

Antigen-detection kits specific to E. histolytica also exist and perform well alongside PCR. Getting the species right changes whether your doctor prescribes an invasive-tissue-active drug or simply monitors you without treatment, so this distinction carries real clinical weight.

Blood Tests and Eosinophil Counts

A routine complete blood count (CBC) sometimes provides the first clue that a parasite infection is present. Eosinophils, a type of white blood cell, tend to rise in response to certain helminth infections. If your doctor sees an elevated eosinophil count and you have relevant risk factors, that result can prompt more targeted stool testing or serology.

Eosinophilia is not a parasite-specific finding; allergies, drug reactions, and autoimmune conditions can all raise the count. And many protozoan infections, including Giardia and Cryptosporidium, typically do not elevate eosinophils at all. So a normal eosinophil count does not rule out a parasite, and a high one does not confirm one. It is a clue, not a diagnosis.

Serologic blood tests that look for antibodies against specific parasites, such as Strongyloides or Schistosoma, fill an important gap. These organisms may not shed reliably into stool, and serologic testing can detect the immune response even when stool exams come back empty. The trade-off is that antibody tests sometimes remain positive long after an infection has been treated, making it hard to distinguish active from past infection.

Endoscopy and Biopsy

Stool-based tests are the backbone of parasite diagnostics, but in some cases the answer comes from looking directly at the gut lining. Endoscopy allows a gastroenterologist to visualize the upper or lower gastrointestinal tract and take tissue biopsies. Parasites that embed in the intestinal wall, such as certain Strongyloides larvae or Entamoeba trophozoites invading colonic tissue, can be identified histologically even when stool exams are negative.

16PubMed. Gastrointestinal parasites presentations and histological diagnosis from endoscopic biopsies and surgical specimens

A study enrolling 300 patients with gastrointestinal symptoms found parasitic stages in stool in about a third of cases using standard techniques. When parasite-positive patients underwent endoscopy with narrow-band imaging, pathological changes in the gut mucosa were visible and helped confirm the diagnosis and assess the extent of tissue damage.

17PubMed. Endoscopic procedure as a diagnostic tool for intestinal parasitic pathological changes

Endoscopy is not a first-line screening tool for parasites. It is reserved for cases where stool tests have been inconclusive, symptoms are severe or chronic, or the doctor suspects a tissue-invasive organism that does not show up reliably in feces.

Fecal Calprotectin as a Supporting Marker

If you have been evaluated for inflammatory bowel disease, you may have encountered fecal calprotectin, a protein released by neutrophils (immune cells) in the gut when inflammation is present. It is not a parasite test per se, but elevated calprotectin can provide supporting evidence that an intestinal infection is causing real inflammation, as opposed to a functional disorder like irritable bowel syndrome.

18PROBLEMS of Infectious and Parasitic Diseases. FECAL CALPROTECTIN LEVELS AND PRESENCE OF HELICOBACTER PYLORI CO-INFECTION IN INDIVIDUALS WITH ENTEROBIASIS

Research has shown that calprotectin levels correlate with intestinal parasitic infections and can offer useful supplementary information alongside routine stool examination and fecal occult blood testing.

19Academic International Journal of Pure Science. Correlation between Intestinal Parasitic Infections and Fecal Calprotectin Levels

It is best thought of as a triage tool: a high calprotectin result in someone with chronic diarrhea and travel history strengthens the case for pursuing more specific parasite testing, while a very low result makes inflammatory causes, parasitic or otherwise, less likely.

Testing in Immunocompromised Patients

People living with HIV or other conditions that suppress the immune system face a different parasite landscape. Organisms that rarely cause problems in healthy individuals, such as Cryptosporidium, Cystoisospora belli, and certain microsporidia, become significant and sometimes life-threatening pathogens when immune defenses are weakened. Reviews of opportunistic infections in HIV/AIDS patients have identified Cryptosporidium parvum, Isospora belli (now Cystoisospora), and Blastocystis hominis among the most common intestinal protozoa in this population, with chronic and persistent diarrhea as a hallmark presentation.

20PubMed Central. Opportunistic parasitic infections in patients with human immunodeficiency virus/acquired immunodeficiency syndrome: A review

Diagnostic strategies in immunocompromised patients often go beyond the standard O&P exam. Modified acid-fast stains are used to detect Cryptosporidium and Cystoisospora oocysts, which are too small or too pale for standard staining methods. A combined acid-fast trichrome stain allows simultaneous screening for Cryptosporidium and microsporidia on a single slide, cutting the number of separate examinations needed.

21PubMed Central. A new acid-fast trichrome stain for simultaneous detection of Cryptosporidium parvum and microsporidial species in stool specimens

PCR panels are especially valuable here because they can detect low-level infections that microscopy would miss, and the clinical consequences of a missed diagnosis in an immunocompromised person are more severe.

Emerging Approaches With Metagenomics

All the tests discussed so far target specific organisms, either visually, by their antigens, or through known DNA sequences. A fundamentally different approach is emerging in research settings: diagnostic metagenomics, which sequences all the genetic material in a stool sample without targeting any organism in advance. In principle, this lets researchers identify bacteria, viruses, and parasites simultaneously from a single sample, without needing to know what they are looking for ahead of time.

22PubMed. Metagenomics for broad and improved parasite detection: a proof-of-concept study using swine faecal samples

A proof-of-concept study using animal fecal samples showed that metagenomic analysis could detect and classify multiple protists, including Blastocystis down to the subtype level, without the primer biases that limit traditional PCR. The approach even identified a Blastocystis subtype not previously reported in that host species. Other analyses have demonstrated that shotgun DNA sequencing of complex fecal specimens could serve as a broad, unbiased detection method for parasites alongside other pathogens.

Metagenomics is not ready for routine clinical use. The cost remains high, the bioinformatics pipeline requires expertise most clinical labs do not have, and reference databases for parasites are far less complete than those for bacteria and viruses. But it represents a plausible future in which a single sample and a single sequencing run could replace the patchwork of microscopy, antigen tests, and targeted PCR panels that current diagnostics require. For now, it remains a research and surveillance tool, but the trajectory is clear.